✦ LIBER ✦

P028 OPEN-LABEL INFLIXIMAB THERAPY IN ULCERATIVE COLITIS: A MULTICENTER SURVEY OF RESULTS AND PREDICTORS OF RESPONSE

✍ Scribed by Y. Gonzalez-Lama

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy, safety, and predictors of resp

✍ Lee, Kang-Moon; Jeen, Yoon Tae; Cho, Ju Yeon; Lee, Chang Kyun; Koo, Ja-Seol; Par 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 508 KB

P060 OPEN-LABEL INFLIXIMAB THERAPY IN CR

✍ Y. González-Lama 📂 Article 📅 2007 🏛 Oxford University Press ⚖ 60 KB

Open-label infliximab therapy in Crohn's

✍ Yago González-Lama; Antonio López-San Román; Ignacio Marín-Jiménez; Begoña Casis 📂 Article 📅 2008 🏛 Elsevier Science 🌐 Spanish ⚖ 98 KB

P447 Infliximab in the treatment of mode

✍ Cappello, M.; Mazza, M.; Costantino, G.; Fries, W.; Privitera, A.C.; Mastronardi 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 51 KB

W1294 Predictors of Primary Non-Response

✍ Oussalah, Abderrahim; Evesque, Ludovic; Laharie, David; Roblin, Xavier; Boschett 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 50 KB

P526 Efficacy, safety, and predictors of

✍ Lee, K.-M.; Jeen, Y.T.; Cho, J.Y.; Lee, C.K.; Park, D.I.; Im, J.-P.; Jung, S.-A. 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 56 KB